SHAPE Versus Milligan-Morgan Hemorrhoidectomy for Hemorrhoidal Disease
This study will be conducted at the General Surgery Department, Kasr Al-Ainy Teaching Hospital, Cairo University, on patients presenting with third- and fourth-degree hemorrhoids. Adult patients older than 18 years who fulfill the inclusion criteria and provide informed consent will be enrolled. Patients with inflammat
| Condition(s) | Hemorrhoid |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This study will be conducted at the General Surgery Department, Kasr Al-Ainy Teaching Hospital, Cairo University, on patients presenting with third- and fourth-degree hemorrhoids. Adult patients older than 18 years who fulfill the inclusion criteria and provide informed consent will be enrolled. Patients with inflammatory bowel disease, anal stenosis, colorectal malignancy, or fecal incontinence will be excluded. All patients will undergo detailed preoperative assessment including medical and surgical history, evaluation of anal symptoms, local anorectal examination, digital rectal examination, and routine laboratory investigations. Participants will be randomized into two groups: Group A will undergo Skin-Sparing Hemorrhoidectomy and PExy (SHAPE), while Group B will undergo conventional M |
| Who can participate | Inclusion Criteria: * All patients with third- and fourth-degree piles, and their age greater than 18 years old Exclusion Criteria: * Patients with inflammatory bowel disease. * Patients with anal stenosis * Patients with colorectal malignancy * Patient with fecal incontinence |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Cairo University |
| Locations | Cairo, Al-Manial, Cairo, Egypt, Egypt |
| Start date | 2026-05-24 |
| NCT ID | NCT07598630 |
| Official listing | https://clinicaltrials.gov/study/NCT07598630 |